by Observer editorial on (#565QJ)
The Recovery drugs trial is a beacon of excellence among the general coronavirus incompetenceBeing British has been a discomforting experience for the past six months. A nation that had prided itself on the strength and resilience of its healthcare system has been laid low by the Covid-19 pandemic, which has claimed nearly 50,000 lives in the UK. Most other western nations have suffered fewer deaths and endured comparatively little national trauma. Not surprisingly, the UK government’s handling of the crisis has been heavily criticised, mostly for its tardiness and incompetence. Britain was too late in going into lockdown and it abandoned its ability to test for the coronavirus when it should have been ramping up capacity. The prime minister has blustered and vacillated over key policies from the wearing of masks to the timing of the easing of lockdown restrictions.Given this sad background, it has been startling to note recent headlines and comments made across the world about the country’s Covid-19 response. “The Brits are on course to save the world,” claimed the US economist Tyler Cowen in Bloomberg Opinion, while the American journal Science was at pains to quote leading international scientists who have heaped praise on our researchers’ anti-Covid work. “UK megatrial outshines other drug studies,” ran one of its headlines. Continue reading...